ASGPR-mediated uptake of multivalent glycoconjugates for drug delivery in hepatocytes - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue ChemBioChem Année : 2016

ASGPR-mediated uptake of multivalent glycoconjugates for drug delivery in hepatocytes

Résumé

Liver cells are an essential target for drug delivery in many diseases. The hepatocytes express the asialoglycoprotein receptor (ASGPR), which promotes specific uptake by means of N-acetylgalactosamine (GalNAc) recognition. In this work, we designed two different chemical architectures to treat Wilson's disease by intracellular copper chelation. Two glycoconjugates functionalized with three or four GalNAc units each were shown to enter hepatic cells and chelate copper. Here, we studied two series of compounds derived from these glycoconjugates to find key parameters for the targeting of human hepatocytes. Efficient cellular uptake was demonstrated by flow cytometry using HepG2 human heptic cells that express the human oligomeric ASGPR. Dissociation constants in the nanomolar range showed efficient multivalent interactions with the receptor. Both architectures were therefore concluded to be able to compete with endogeneous asialoglycoproteins and serve as good vehicles for drug delivery in hepatocytes.

Dates et versions

hal-01298035 , version 1 (05-04-2016)

Identifiants

Citer

Marie Monestier, Peggy Charbonnier, Christelle Gateau, Martine Cuillel, Faustine Robert, et al.. ASGPR-mediated uptake of multivalent glycoconjugates for drug delivery in hepatocytes. ChemBioChem, 2016, 17 (7), pp.590-594. ⟨10.1002/cbic.201600023⟩. ⟨hal-01298035⟩
216 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More